首页> 外文期刊>Arthritis research & therapy. >Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway
【24h】

Interleukin-17A promotes functional activation of systemic sclerosis patient-derived dermal vascular smooth muscle cells by extracellular-regulated protein kinases signalling pathway

机译:白细胞介素17A通过细胞外调节蛋白激酶信号通路促进系统性硬化症患者源性真皮血管平滑肌细胞的功能激活

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Dermal vascular smooth muscle cells (DVSMCs) are important for vascular wall fibrosis in microangiopathy of systemic sclerosis (SSc). T helper 17 cell-associated cytokines, particularly interleukin-17A (IL-17A), have been demonstrated to play a role in the pathogenesis of SSc. However, the effect of IL-17A on the DVSMCs in microangiopathy of SSc has not been established. In the present study, we investigated the effect of IL-17A on the SSc patient-derived DVSMCs.
机译:简介:皮肤血管平滑肌细胞(DVSMC)对于系统性硬化症(SSc)的微血管病中的血管壁纤维化很重要。 T辅助细胞17细胞相关的细胞因子,尤其是白介素17A(IL-17A),已被证明在SSc的发病机理中起作用。然而,尚未确定IL-17A对SSc微血管病中DVSMCs的作用。在本研究中,我们调查了IL-17A对SSc患者来源的DVSMC的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号